Related Experiment Video

Updated: Mar 20, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

845

Assessment of Lung Cancer Treatment by Disease Phase Using National Cancer Registry Data Linked with Treatment

G Zauner1, N Popper1, F Breitenecker2

  • 1dwh GmbH, Vienna, Austria.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|May 21, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.4K

Related Experiment Videos

Last Updated: Mar 20, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

845
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.4K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

819
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
819

Articles linked to this work by shared authors, journal, and citation graph.

Evaluation of re-depositing hydropower trapped sediments at large rivers to improve flood protection and aquatic habitats - Case study Danube/Austria.

The Science of the total environment·2023

Evaluation of undetected cases during the COVID-19 epidemic in Austria.

BMC infectious diseases·2021

The association of smoking with IGRA and TST results in HIV-1-infected subjects.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2014

Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels.

Journal of viral hepatitis·2013

The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV.

The Journal of infection·2012

Glycan labeling strategies and their use in identification and quantification.

Analytical and bioanalytical chemistry·2010

An Application of Iterative Health Economic Evaluation: An Update on the Early Cost Effectiveness of Whole-Genome Sequencing in Advanced Non-small-Cell Lung Cancer.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Does conventional cost-effectiveness analysis disadvantage treatments for severe disease? Evidence from U.S. value assessments.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Incorporating Equity Considerations Related to Financial Protection Through Extended Cost-Effectiveness Analysis: A Systematic Review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

How Long Should We Wait? The Impact of Immature Data on Colorectal Cancer Decision Modeling.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

What Age is Appropriate for Self-Reporting EQ-5D-Y-3L? Chinese Insights from a Sample of Children Aged 6-11 years.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

How National Volume-Based Procurement Reshapes Drug Prices and Public Spending in China.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us